Log in
Enquire now
‌

US Patent RE46617 Process for making quinolone compounds

Patent RE46617 was granted and assigned to Melinta Therapeutics on November, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Melinta Therapeutics
Melinta Therapeutics
0
Current Assignee
Melinta Therapeutics
Melinta Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
RE466170
Patent Inventor Names
Roger Hanselmann0
Graham Johnson0
Maxwell M. Reeve0
Date of Patent
November 28, 2017
0
Patent Application Number
147433650
Date Filed
June 18, 2015
0
Patent Primary Examiner
‌
Dwayne C. Jones
0
Patent abstract

The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent RE46617 Process for making quinolone compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.